Decoy Therapeutics is trading 5.6% down at $1.35 as of 9:37 a.m. EST on October 13, 2026, with no clear company-specific announcement or confirmed catalyst found in available reporting.
- An October 7 prospectus covers resale of up to 2,368,868 shares issuable upon warrant exercise; available sources do not establish it as the cause of the decline.
- Broader index moves are mixed and do not clearly explain the decline.